A leading global healthcare investment fund has offered $70 million to Pinnacle Blooms Network, the flagship pediatric-therapy enterprise of Hyderabad-based startup Bharath Healthcare Laboratories.
The proposed two-tranche Series A investment, advised by Yukon Capital, would represent one of the largest early-stage financings in child-development infrastructure anywhere in Asia. The offer comes as Pinnacle evaluates strong interest from multiple global institutional investors seeking exposure to the fast-emerging developmental health sector.
Pinnacle operates more than 70 multi-disciplinary therapy centres across India - and has delivered over 20 million one-to-one therapy sessions to date. The company's proprietary Pinnacle Child Development Operating System (GPT-OS®) is a multi-patent-filed digital-therapeutic platform that measures, forecasts, and personalises every dimension of a child's developmental journey across speech, motor, cognitive, and behavioural domains.
The GPT-OS® architecture integrates modules including Diagnosis, Prognosis, TherapeuticAI®, AbilityScore®, Seven Readiness Indexes®, and TherapySphere™—multi-sensory therapeutic environments designed to accelerate neurological development in children with autism, speech delays, ADHD, and related conditions.
The proposed funding is structured in two phases. Phase 1 comprises $70 million for rapid domestic expansion and technology acceleration. Phase 2 envisions a follow-on tranche as Pinnacle expands into Southeast Asia and the GCC. Capital deployment would fund expansion from 70+ to 300 centres within 24 months, R&D acceleration for home-based TherapeuticAI® applications, large-scale manufacturing of TherapySphere™ sensory rooms, and regulatory submissions for international market access.
Pinnacle is targeting expansion with projected annual revenue scaling from Rs 160+ crore to Rs 6,000 crore.
